Literature DB >> 27408442

Kaposiform Hemangioendothelioma in a 3 Months Old Infant.

Ramya Uppuluri1, Vimal Kumar1, Deenadayalan Munirathnam1, Hemalatha Doss1, Sreejith Ramachandrakurup1, Divya Subburaj1, Revathi Raj1.   

Abstract

Kaposiform hemangioendothelioma is a rare, highly vascular and aggressive soft tissue tumor frequently associated with Kasabach-Merritt phenomenon, usually seen in early infancy. Early diagnosis by means of MRI and tissue biopsy portends a better outcome. Treatment includes surgical excision when feasible and medical management with steroids, propranolol, vincristine and supportive treatment for coagulopathy. We report a 3 months old female infant who was diagnosed, treated successfully and is now in complete remission.

Entities:  

Keywords:  Kaposiform hemangioendothelioma; Kasabach–Merritt phenomenon; Remission; Steroids; Vascular soft tissue tumor; Vincristine

Year:  2016        PMID: 27408442      PMCID: PMC4925564          DOI: 10.1007/s12288-016-0674-y

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  3 in total

1.  Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.

Authors:  Yvonne E Chiu; Beth A Drolet; Francine Blei; Manuel Carcao; Jason Fangusaro; Michael E Kelly; Alfons Krol; Sabra Lofgren; Anthony J Mancini; Denise W Metry; Michael Recht; Robert A Silverman; Wynnis L Tom; Elena Pope
Journal:  Pediatr Blood Cancer       Date:  2012-02-02       Impact factor: 3.167

2.  Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma.

Authors:  Lisa L Lyons; Paula E North; Fernand Mac-Moune Lai; Mark H Stoler; Andrew L Folpe; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2004-05       Impact factor: 6.394

3.  [Vincristine treatment for function- and life-threatening infantile hemangioma].

Authors:  O Enjolras; G M Brevière; G Roger; M Tovi; B Pellegrino; E Varotti; V Soupre; A Picard; G Leverger
Journal:  Arch Pediatr       Date:  2004-02       Impact factor: 1.180

  3 in total
  1 in total

1.  Beta-adrenergic receptors are expressed across diverse cancers.

Authors:  Steven L Rains; Clarissa N Amaya; Brad A Bryan
Journal:  Oncoscience       Date:  2017-08-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.